TY - JOUR
T1 - Management of dyspepsia and Helicobacter pylori infection
T2 - the 2022 Indonesian Consensus Report
AU - Syam, Ari Fahrial
AU - Miftahussurur, Muhammad
AU - Makmun, Dadang
AU - Abdullah, Murdani
AU - Rani, Abdul Aziz
AU - Siregar, Gontar Alamsyah
AU - Simadibrata, Marcellus
AU - Zubir, Nasrul
AU - Dewa Nyoman Wibawa, I.
AU - Purnomo, Hery Djagat
AU - Manan, Chudahman
AU - Djojoningrat, Dharmika
AU - Fauzi, Achmad
AU - Renaldi, Kaka
AU - Maulahela, Hasan
AU - Pribadi, Rabbinu Rangga
AU - Muzellina, Virly Nanda
AU - Nursyirwan, Saskia Aziza
AU - Idrus, Muhammad Firhat
AU - Ruswhandi, Ruswhandi
AU - Sugihartono, Titong
AU - Bestari, Muhammad Begawan
AU - Bayupurnama, Putut
AU - Pramana, Triyanta Yuli
AU - Wibowo, Bogi Pratomo
AU - Bakry, Achmad Fuad
AU - Akil, Fardah
AU - Parewangi, Andi Muhammad Luthfi
AU - Widita, Haris
AU - Mariadi, I. Ketut
AU - Murti, Ignatia Sinta
AU - Yusuf, Ali Imron
AU - Arles, Arles
AU - Yusuf, Fauzi
AU - Waleleng, Bradley Jimmy
AU - Abimanyu, Abimanyu
AU - Mulyadi, Yustar
AU - Lucida, Maria Inge
AU - Rezkhita, Yudith Annisa Ayu
AU - Alfaray, Ricky Indra
AU - Yamaoka, Yoshio
AU - Utari, Amanda Pitarini
N1 - Funding Information:
This work is supported by the Directorate of Research and Community Service, Deputy for Strengthening Research and Development Ministry of Research and Technology/Research Agency and National Innovation, Indonesia.
Publisher Copyright:
© 2023, The Author(s).
PY - 2023/12
Y1 - 2023/12
N2 - Dyspepsia still becomes a major challenge in upper gastrointestinal disease in Indonesia. This disease often correlated with Helicobacter pylori infection. However, the prevalence of this bacterium is generally low in Indonesia. Therefore, several considerations should be taken into consideration during the management of dyspepsia and H. pylori infection. “Management of dyspepsia and H. pylori infection in Indonesia: The Indonesian consensus report” comprises information gathered from 22 gastroenterology centers across Indonesia. The experts gathered to evolve a consensus, that consists of the statements, grades of recommendations, evidence levels, and rationales for the dyspepsia and H. pylori infection management for daily clinical practice. The report explains several aspects from the updated epidemiology information to comprehensive management therapy. After the experts worked together on all statements in the recommendations, the results are presented with the final agreement as a consensus to help clinicians in understanding, diagnosing, and treating dyspepsia and H. pylori infection patients in daily clinical practice in Indonesia.
AB - Dyspepsia still becomes a major challenge in upper gastrointestinal disease in Indonesia. This disease often correlated with Helicobacter pylori infection. However, the prevalence of this bacterium is generally low in Indonesia. Therefore, several considerations should be taken into consideration during the management of dyspepsia and H. pylori infection. “Management of dyspepsia and H. pylori infection in Indonesia: The Indonesian consensus report” comprises information gathered from 22 gastroenterology centers across Indonesia. The experts gathered to evolve a consensus, that consists of the statements, grades of recommendations, evidence levels, and rationales for the dyspepsia and H. pylori infection management for daily clinical practice. The report explains several aspects from the updated epidemiology information to comprehensive management therapy. After the experts worked together on all statements in the recommendations, the results are presented with the final agreement as a consensus to help clinicians in understanding, diagnosing, and treating dyspepsia and H. pylori infection patients in daily clinical practice in Indonesia.
KW - Dyspepsia
KW - Helicobacter pylori infection
KW - Human and illness
KW - Indonesia
KW - Management
UR - http://www.scopus.com/inward/record.url?scp=85160102666&partnerID=8YFLogxK
U2 - 10.1186/s13099-023-00551-2
DO - 10.1186/s13099-023-00551-2
M3 - Review article
AN - SCOPUS:85160102666
SN - 1757-4749
VL - 15
JO - Gut Pathogens
JF - Gut Pathogens
IS - 1
M1 - 25
ER -